Stock listing

NASDAQ:PSTX Poseida Therapeutics Inc Stock

Follow Poseida Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:PSTX

$9.50 USD

Close on Jan 7, 2025 · No longer trades

Jul 10, 2020 to last close -38.1% · weekly closes, Jul 10, 2020 – Jan 7, 2025
Lowest – highest close
$1.62 – $16.25 USDSince Jul 10, 2020 · lowest Aug 3, 2023 · highest Jul 20, 2020

Delisted NASDAQ:PSTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:PSTX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Poseida Therapeutics Inc on 6ix

Decks
7 decks · latest Nov 14, 2024

Decks

DeckKindSlidesDate
Investor Day (November 2024)Investor day73 slidesNov 14, 2024
Investor Day (April 2024)Investor day87 slidesApr 17, 2024
Investor Day (February 2023)Investor day145 slidesFeb 22, 2023
Investor Presentation (August 2022)Investor deck16 slidesAug 3, 2022
Investor Day (February 2022)Investor day180 slidesFeb 23, 2022
Technical Presentation (February 2022)Technical6 slidesFeb 17, 2022
Technical Presentation (August 2021)Technical16 slidesAug 31, 2021

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John Schmid
Other companies: BlossomHill Therapeutics, Inc. (Director · Since at least Aug 6, 2026); First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); Helix Acquisition Corp. III (Director · Since at least Jan 22, 2026); Design Therapeutics, Inc. (Director · Since at least Mar 25, 2021); AnaptysBio, Inc. (Director · Since at least Feb 2, 2018); BridgeBio Oncology Therapeutics, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past); Xeris Biopharma Holdings, Inc. (Director · Oct 5, 2021 – Aug 12, 2024 · Past); MoonLake Immunotherapeutics (Director · Oct 19, 2020 – Oct 19, 2020 · Past); Neos Therapeutics Inc (Director · Jul 2, 2018 – Mar 19, 2021 · Past)
Director · Jul 9, 2020 – Jan 8, 2025 · Past
Charles Baum
Other companies: Acrivon Therapeutics, Inc. (Director · Since at least Jun 22, 2023); PMV Pharmaceuticals, Inc. (Director · Since at least Apr 1, 2021); Tango Therapeutics, Inc. (Director · Sep 2, 2020 – Sep 2, 2020 · Past); Immunomedics Inc (Director · Feb 23, 2019 – Oct 23, 2020 · Past)
Director · May 16, 2022 – Jan 8, 2025 · Past
David Hirsch
Other companies: Rapid Micro Biosystems, Inc. (Director · Jul 14, 2021 – May 23, 2024 · Past); Tricida Inc (Director · Jun 27, 2018 – Jun 15, 2022 · Past); Molecular Templates Inc (Director · Aug 1, 2017 – Jun 3, 2022 · Past); Collegium Pharmaceutical, Inc. (Director · May 6, 2015 – May 20, 2020 · Past)
Director · Jul 9, 2020 – Jul 23, 2021 · Past
Rafael G. Amado
Other companies: Zai Lab Ltd. (President, Head of Global Research and Development · Since at least Dec 30, 2022); Allogene Therapeutics, Inc. (EVP of R&D · Sep 3, 2019 – Oct 7, 2022 · Past); Adaptimmune Therapeutics PLC (President, R&D · Jan 1, 2016 – Aug 6, 2019 · Past)
Director · Apr 13, 2023 – Jan 8, 2025 · Past
Sean Murphy
Other companies: TriSalus Life Sciences, Inc. (Director · Since at least Aug 10, 2023); Radius Health, Inc. (Director · Aug 10, 2020 – Aug 15, 2022 · Past); Novan Inc (Director · Sep 20, 2016 – Jun 4, 2018 · Past)
Director · Jul 9, 2020 – Jul 14, 2020 · Past
Syed Ali-aamir Rizvi
Other companies: Rocket Pharmaceuticals, Inc. (Chief Medical Officer · Since at least Sep 15, 2025); Caribou Biosciences, Inc. (Chief Medical Officer · Jan 18, 2022 – Feb 21, 2023 · Past)
Chief Medical Officer · Apr 1, 2024 – Jan 8, 2025 · Past
Harry J Leonhardt
Other companies: Halozyme Therapeutics, Inc. (SVP, GC · Apr 13, 2016 – Apr 13, 2019 · Past)
GC & Chief Compliance Officer · Sep 15, 2020 – Jan 8, 2025 · Past
Marcea Bland Lloyd
Other companies: Amylin Pharmaceuticals LLC (SVP, Chief Administrative Offi · Mar 1, 2011 – Feb 8, 2012 · Past)
Director · Jul 9, 2020 – Jan 8, 2025 · Past
Brent WarnerPresident, Gene Therapy · Feb 21, 2022 – Mar 1, 2024 · Past
Johanna MyletChief Financial Officer · Jul 9, 2020 – Jan 8, 2025 · Past
All 13 people
PersonSeat
Kerry D IngallsChief Operating Officer · Jul 9, 2020 – Mar 16, 2022 · Past
Luke CorningDirector · Dec 16, 2020 – Jan 8, 2025 · Past
Mark J GergenPresident and CEO, Director · Feb 1, 2023 – Jan 8, 2025 · Past

Open People

Log in to ask 6ix AI your own questions about Poseida Therapeutics Inc.